Join Mocuis at the Bio International Convention 2015 in Philadelphia
Our CEO, Jenny (Seungyun) Jo, will participate in an interactive speaker panel along with representatives from Eli Lilly and Quintiles. The session will cover bringing novel drugs from lower regulated territories, such as South Korea and China, to higher regulated territories.
Increasingly, companies in the emerging markets are conducting drug discovery to address local health needs. Helping to fuel this innovation are government investment in R&D and facilities, policy changes that favor regulatory review of novel products instead of approving the “nth” generic, and stronger IP protection. When novel, patented products achieve commercialization first in emerging markets, the innovators may try to attract foreign licensees, or may be approached by specialty pharmas looking to secure developed market rights to these low-risk assets. The session will examine this “reverse innovation” that’s moving novel products to – not from – advanced economies and the regulatory hurdles that are constricting this reverse new product flow.
10:15 AM–11:30 AM Jun 17, 2015